Thor Medical ASA (TRMED.OL)
NOK 2.66
(1.92%)
NOK 2.66
(1.92%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -64.09 Million | -409.07 Million | -403.45 Million | -398.2 Million | - |
| Net Income | -26.56 Million | -310.37 Million | -440.13 Million | -416.16 Million | - |
| Depreciation & Amortization | 717 Thousand | 11.2 Million | 11.37 Million | 14.89 Million | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 2.1 Million | -3.3 Million | 7.59 Million | -7.46 Million | - |
| Change in working capital | -32.4 Million | -97.97 Million | 20.49 Million | 31.19 Million | - |
| Other non-cash items | -5.98 Million | -3.09 Million | -708 Thousand | -1.11 Million | - |
| Investing Cash Flow | 6.27 Million | -2.46 Million | 863 Thousand | 1.4 Million | - |
| Investments in PPE | - | -5.62 Million | -259 Thousand | -185 Thousand | -1.06 Million |
| Acquisitions | 4.25 Million | - | - | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | 2.01 Million | - | - | - | - |
| Financing Cash Flow | -332 Thousand | 228.12 Million | 385.09 Million | 201.46 Million | - |
| Debt repayment | -159.00 | - | - | - | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 147 Thousand | 250.8 Million | 423.56 Million | 231.5 Million | - |
| Other Financing Activities | -1000.00 | - | - | - | - |
| Accounts receivables | - | - | - | - | - |
| Accounts payables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Other working capital | -32.4 Million | - | - | - | - |
| Cash at beginning of period | 98.71 Million | 277.7 Million | 293.97 Million | 470.82 Million | - |
| Cash at end of period | 41.76 Million | 98.71 Million | 277.7 Million | 293.97 Million | - |
| Capital Expenditure | - | -5.62 Million | -259 Thousand | -185 Thousand | -1.06 Million |
| Effect of forex changes on cash | 1.19 Million | 4.42 Million | 1.22 Million | 18.49 Million | - |
| Net cash flow / Change in cash | -56.94 Million | -178.99 Million | -16.26 Million | -176.84 Million | - |
| Free Cash Flow | -64.09 Million | -414.7 Million | -403.71 Million | -398.39 Million | -1.06 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -6500.00 | -6500.00 | -26.56 Million | -13.25 Thousand | -13.25 Thousand | -310.37 Million |
| Depreciation & Amortization | 200.00 | 200.00 | 717 Thousand | - | - | 11.2 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 400.00 | 400.00 | 2.1 Million | - | - | -3.3 Million |
| Change in working capital | -300.00 | -300.00 | -32.4 Million | - | - | -97.97 Million |
| Other non-cash items | -50.00 | -50.00 | -5.98 Million | -11.25 Thousand | -11.25 Thousand | -3.09 Million |
| Investing Cash Flow | - | - | 6.27 Million | 50.00 | 50.00 | -2.46 Million |
| Investments in PPE | - | - | - | - | - | -5.62 Million |
| Acquisitions | - | - | 4.25 Million | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | 50.00 | 50.00 | - |
| Financing Cash Flow | 150.00 | 150.00 | -332 Thousand | -100.00 | -100.00 | 228.12 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 147 Thousand | - | - | 250.8 Million |
| Other Financing Activities | 150.00 | 150.00 | -1000.00 | -100.00 | -100.00 | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -300.00 | -300.00 | - | - | - | - |
| Cash at beginning of period | - | - | 98.71 Million | 74.45 Thousand | - | 277.7 Million |
| Cash at end of period | -6100.00 | -6100.00 | 41.76 Million | 50.2 Thousand | -24.25 Thousand | 98.71 Million |
| Capital Expenditure | - | - | - | - | - | -5.62 Million |
| Effect of forex changes on cash | - | - | 1.19 Million | 300.00 | 300.00 | 4.42 Million |
| Net cash flow / Change in cash | -6100.00 | -6100.00 | -56.94 Million | -24.25 Thousand | -24.25 Thousand | -178.99 Million |
| Free Cash Flow | -6250.00 | -6250.00 | -64.09 Million | -24.5 Thousand | -24.5 Thousand | -414.7 Million |
UCOBANK
4513
3325
4510
1541
UFCS